Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment

Saved in:
Bibliographic Details
Published in:Leukemia & lymphoma 2016-10, Vol.57 (10), p.2425-2428
Main Authors: Amorim, Sandy, Fleury, Isabelle, Mounier, Nicolas, Harel, Stéphanie, Brice, Pauline, Thieblemont, Catherine
Format: Article
Language:English
Subjects:
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Chemotherapy, Adjuvant
Combined Modality Therapy
Consolidation Chemotherapy - methods
Drug Resistance, Neoplasm - drug effects
Etoposide - administration & dosage
Etoposide - adverse effects
Female
Humans
Ifosfamide - administration & dosage
Ifosfamide - adverse effects
Lymphoma, Large B-Cell, Diffuse - mortality
Lymphoma, Large B-Cell, Diffuse - pathology
Lymphoma, Large B-Cell, Diffuse - therapy
Male
Middle Aged
Mitoxantrone - administration & dosage
Mitoxantrone - adverse effects
Recurrence
Retrospective Studies
Rituximab - administration & dosage
Stem Cell Transplantation - methods
Treatment Outcome
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1042-8194
1029-2403
DOI:10.3109/10428194.2015.1135437